For more than 20 years, WorldCare Clinical has been a leading provider of imaging services on Cardiovascular drug and device trials.
Our team has provided imaging CRO services on Phase I-IV drug and device trials across Cardiovascular indications, including:
- Acute and Chronic Heart Failure
- Acute Coronary Syndromes
- Acute Peripheral Arterial Occlusion
- Atrial Fibrillation
- Cardiac Surgery
- Carotid Artery Disease
- Congestive Heart Failure
- Coronary Artery Disease
- Fabry Disease
- Myocardial Infarction
- Pulmonary and Arterial Hypertension
We have experience with a variety of cardiovascular evaluation criteria, including:
- CAC Scoring
- Clip Placement
- Echo Assessments (Doppler, 2&3D Structure and Function, and Contrast Enhancement)
- LAA Assessments
- Quantitative Evaluation of PV and CA Stenosis
- Safety Assessments
ModalitiesWe have extensive experience with Cardiovascular studies in the U.S. and Europe involving the following modalities: - Angiography
- PET and SPECT Myocardial Perfusion Imaging
- Pulmonary Angiography
- Transesophageal Echocardiograms (TEE)
- V/Q Lung Scan
Our dedicated team of cardiologists and radiologists, technicians, regulatory experts, and project managers is among the most knowledgeable and well-respected in the industry. Our services also include safety monitoring.
Study designOur experts work with sponsors to design trials which ensure high-quality results in a cost-effective manner. We collaborate with sponsors in workflow design and imaging charter development to establish the foundation necessary to meet the sponsor's clinical trial goals.
Reader trainingThrough a combination of our expert radiologists and our rigorous training and testingregimen, we are committed to increasing the accuracy and precision of data subject to blinded independent central review. Sponsors have the flexibility of working with our highly-trained in-house radiologists, with sub-specialty-trained board-certified radiologists from the Harvard Hospital System, or with other radiologists of the sponsor's choice.
Web-based technology platformOur state-of-the-art systems are 21 CRF Part 11 compliant and are used to analyze images from all modalities. The systems can be accessed by radiologists to perform assessments anywhere in the world. Thousands of clinical sites in the U.S., Latin America, Europe, and Asia-Pacific have uploaded imaging data directly into our secure system.
Regulatory experienceWe have an extensive history in preparing submissions for regulatory approval by the U.S. Food and Drug Administration (FDA) Medical Imaging Division and the European Medicines Agency (EMA). Our Quality Management System is designed to provide the structure and controls required to support execution of the clinical study, while ensuring that processes meet current regulatory standards.
You can learn more about imaging in Cardiovascular clinical trials by reviewing our publications below. To learn more about our Cardiovascular imaging services, please contact us at +1.888.816.4721.
Treatment for Cerebral Small Vessel Disease
Response of Atherosclerosis to Treatment
PET Accurate for Evaluation of Sarcoma Response to Therapy